Joshua Aiello

CIK: 0001960418

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)6 (66.7%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

OBIO

Orchestra BioMed Holdings, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (9 total)

OBIO
Orchestra BioMed Holdings, Inc.
Aug 26, 2026
Tax Payment(F)
Direct
203 shares at avg. $5.26$1K
OBIO
Orchestra BioMed Holdings, Inc.
Mar 25, 2026
Tax Payment(F)
Direct
241 shares at avg. $4.57$1K
OBIO
Orchestra BioMed Holdings, Inc.
Feb 12, 2026
Award(A)
Stock Option (Right to Buy)
Direct
70K shares-
OBIO
Orchestra BioMed Holdings, Inc.
Jan 2, 2026
Tax Payment(F)
Direct
241 shares at avg. $4.31$1K
OBIO
Orchestra BioMed Holdings, Inc.
Sep 17, 2025
Tax Payment(F)
Direct
203 shares at avg. $2.46$499.38
OBIO
Orchestra BioMed Holdings, Inc.
Aug 7, 2025
Award(A)
Direct
15K shares-
OBIO
Orchestra BioMed Holdings, Inc.
Jun 18, 2025
Tax Payment(F)
Direct
393 shares at avg. $2.99$1K
OBIO
Orchestra BioMed Holdings, Inc.
Apr 4, 2025
Award(A)
Stock Option (Right to Buy)
Direct
48K shares-
OBIO
Orchestra BioMed Holdings, Inc.
Mar 26, 2025
Tax Payment(F)
Direct
278 shares at avg. $4.38$1K

		Type	Shares	Price		Ownership
Aug 26, 2026	OBIO Orchestra BioMed Holdings, Inc.	Tax Payment(F)	203	$5.26	$1,068	Direct
Mar 25, 2026	OBIO Orchestra BioMed Holdings, Inc.	Tax Payment(F)	241	$4.57	$1,101	Direct
Feb 12, 2026	OBIO Orchestra BioMed Holdings, Inc.	Award(A) Stock Option (Right to Buy)	70,000	-	-	Direct
Jan 2, 2026	OBIO Orchestra BioMed Holdings, Inc.	Tax Payment(F)	241	$4.31	$1,039	Direct
Sep 17, 2025	OBIO Orchestra BioMed Holdings, Inc.	Tax Payment(F)	203	$2.46	$499	Direct
Aug 7, 2025	OBIO Orchestra BioMed Holdings, Inc.	Award(A)	15,000	-	-	Direct
Jun 18, 2025	OBIO Orchestra BioMed Holdings, Inc.	Tax Payment(F)	393	$2.99	$1,175	Direct
Apr 4, 2025	OBIO Orchestra BioMed Holdings, Inc.	Award(A) Stock Option (Right to Buy)	48,000	-	-	Direct
Mar 26, 2025	OBIO Orchestra BioMed Holdings, Inc.	Tax Payment(F)	278	$4.38	$1,218	Direct

1-9 of 9 transactions

About Aiello Joshua

Aiello Joshua (SEC CIK 0001960418) files insider reports with the SEC as Principal Accounting Officer of Orchestra BioMed Holdings, Inc. (OBIO).

Signal8 holds 9 ownership filings by Aiello Joshua, all Form 4s, filed between Mar 28, 2025 and Aug 28, 2026. Those filings report 9 transactions, from Mar 26, 2025 to Aug 26, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Aiello Joshua's filings is in NEW HOPE, PA.

Recent filings by Aiello Joshua

Aug 26, 2026: Tax withholding of OBIO shares (Form 4, code F).
Mar 25, 2026: Tax withholding of OBIO shares (Form 4, code F).
Feb 12, 2026: Grant or award of OBIO derivative securities (Form 4, code A).
Jan 2, 2026: Tax withholding of OBIO shares (Form 4, code F).
Sep 17, 2025: Tax withholding of OBIO shares (Form 4, code F).

Other insiders filing for Orchestra BioMed Holdings, Inc. (OBIO)

Sherman Darren
Hochman David P
Taylor Andrew Lawrence, Chief Financial Officer
Pacitti David, Director
Fain Eric S, Director
Mack John Prosper, Director

How to read Form 4 transaction codes